Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Cryoport Company

CYRX
US2290503075
A14THD

Price

7.55
Today +/-
+0.39
Today %
+5.72 %
P

Cryoport stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Cryoport stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Cryoport stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Cryoport stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Cryoport's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Cryoport Stock Price History

DateCryoport Price
10/18/20247.55 undefined
10/17/20247.13 undefined
10/16/20247.26 undefined
10/15/20247.39 undefined
10/14/20247.13 undefined
10/11/20246.98 undefined
10/10/20246.67 undefined
10/9/20246.78 undefined
10/8/20246.96 undefined
10/7/20247.88 undefined
10/4/20247.89 undefined
10/3/20247.87 undefined
10/2/20248.42 undefined
10/1/20248.21 undefined
9/30/20248.11 undefined
9/27/20248.00 undefined
9/26/20247.97 undefined
9/25/20247.93 undefined
9/24/20247.95 undefined
9/23/20248.01 undefined

Cryoport Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cryoport, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cryoport from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cryoport’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cryoport. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cryoport’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cryoport’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cryoport’s growth potential.

Cryoport Revenue, EBIT and net profit per share

DateCryoport RevenueCryoport EBITCryoport Net Income
2026e281.12 M undefined-40.8 M undefined-39.35 M undefined
2025e256.87 M undefined-50.08 M undefined-50.62 M undefined
2024e235.82 M undefined-102.47 M undefined-124.15 M undefined
2023233.26 M undefined-65.59 M undefined-107.59 M undefined
2022237.3 M undefined-31.9 M undefined-45.3 M undefined
2021222.6 M undefined-17.8 M undefined-283.7 M undefined
202078.7 M undefined-30 M undefined-75 M undefined
201933.9 M undefined-17.7 M undefined-18.3 M undefined
201819.6 M undefined-8.6 M undefined-9.6 M undefined
201712 M undefined-7.9 M undefined-7.9 M undefined
20166.1 M undefined-6.1 M undefined-10.4 M undefined
20155.9 M undefined-8.7 M undefined-15.1 M undefined
20143.9 M undefined-5.6 M undefined-12.2 M undefined
20132.7 M undefined-5.1 M undefined-19.6 M undefined
20121.1 M undefined-6.3 M undefined-6.4 M undefined
2011600,000 undefined-7.4 M undefined-7.8 M undefined
2010500,000 undefined-5.6 M undefined-6.2 M undefined
2009100,000 undefined-4.2 M undefined-5.7 M undefined
20080 undefined-3.2 M undefined-16.7 M undefined
2007100,000 undefined-3 M undefined-4.6 M undefined
2006100,000 undefined-2.1 M undefined-2.3 M undefined

Cryoport Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0000001235612193378222237233235256281
-------100.0050.0066.6720.00100.0058.3373.68136.36184.626.76-1.690.868.949.77
--------33.3320.0033.3350.0052.6351.5246.1543.2443.4642.49---
0000000011261017369610399000
-2-3-3-4-5-7-6-5-5-8-6-7-8-17-30-17-31-65-102-50-40
-------600.00-250.00-166.67-160.00-100.00-58.33-42.11-51.52-38.46-7.66-13.08-27.90-43.40-19.53-14.23
-2-4-16-5-6-7-6-19-12-15-10-7-9-18-75-283-45-107-124-50-39
-100.00300.00-68.7520.0016.67-14.29216.67-36.8425.00-33.33-30.0028.57100.00316.67277.33-84.10137.7815.89-59.68-22.00
0.30.30.30.41.12.43.14.157.315.42328.233.438.645.94948.74000
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The Cryoport Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cryoport is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
200620072008200920102011201220132014201520162017201820192020202120222023
                                   
0.32.20.23.69.34.60.60.41.42.84.51547.394.393.3628.8523.3456.76
0000.10.10.10.20.50.611.21.63.57.131.439.443.942.07
000000000000000000
0.10.10.5000.1000.10.10.10.10.20.510.516.527.726.21
00.40.30.20.60.30.10.20.10.20.30.50.81.111.98.89.310.08
0.42.713.9105.10.91.12.24.16.117.251.8103147.1693.5604.2535.11
00.20.20.60.70.70.50.40.31.31.62.54.416.344.169.790.5117.51
000000000000000000
000000000000000000
000.30.30.40.40.30.20.1000.10.15.2213.9201.4191194.38
000000000000011145.3147151.1108.4
00.50.10000000.40.40.40.40.421.422.34
00.70.60.91.11.10.80.60.41.7234.932.9405.3419.5434.6422.63
00000.010.010000.010.010.020.060.140.551.111.040.96
                                   
00000000.10000002.810.418.326.32
0.010.010.030.050.060.060.060.080.10.120.130.150.180.290.571.11.111.13
-9.4-13.9-30.6-45.9-52.1-59.9-66.3-85.9-97.8-113.1-123.5-131.4-141-159.3-192-467.5-542.8-642.42
000000000000005.4-1.2-34.5-26.07
000000000000000000
-2.40-4.7-0.95.93.7-2.1-2.3-0.53.15.717.938.5126.3382.7642555.9489.02
0.30.20.20.80.50.40.90.60.81.31.21.21.72.524.828.62827
0.30.30.30.30.40.20.20.50.70.50.40.91.32.69.713.512.216.78
0000.30.20000000.10.10.40.50.60.61.4
0.10.10.10.10.10001.5000000000
0.21.14.10.42.10.41.4300.40.7000000.10.44
0.91.74.71.93.312.54.132.22.32.23.15.53542.740.945.61
1.91.71.63.81.81.41.3000.60014.70116.4405.3407.3380.84
000000000000005.944.92.82
00000000000.20.20.34.112.419.229.839.45
1.91.71.63.81.81.41.3000.60.20.2154.1134.7428.5442423.11
2.83.46.35.75.12.43.84.132.82.52.418.19.6169.7471.2482.9468.72
00000.010.010000.010.010.020.060.140.551.111.040.96
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cryoport provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cryoport's financial health and stability.

Assets

Cryoport's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cryoport must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cryoport after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cryoport's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (k)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2006200720082009201020112012201320142015null20162017201820192020202120222023
-2-4-16-5-6-7-6-19-7-9-9-10-7-9-18-32-275-37-99
0000000000000029202227
000000000000000000-1
0000000000000-1-2-1-7-280
1314210015374971234192856195
0000000000000001333
00000000000000001,0001,0001,000
0-1-2-2-4-6-4-4-4-6-6-3-3-3-1-148-10
000000000-1-10-1-2-5-9-25-24-44
000000000-1-10-1-12-62-382-469-5936
0000000000000-9-57-372-444-3580
0000000000000000000
03010-2140-1-10014011436-3-25
000100004990161974274527-351
0406102045886153874385564-39-23
0003114000006040-4000
0000000000000000000
01-135-4-40111110229-10102-1029
-0.71-2-2.7-3-5.28-7.17-4.97-4.52-4.2-7.430-4.4-5.38-6.31-6.73-24.54-16.88-26.05-45.66
0000000000000000000

Cryoport stock margins

The Cryoport margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cryoport. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cryoport.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cryoport's sales revenue. A higher gross margin percentage indicates that the Cryoport retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cryoport's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cryoport's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cryoport's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cryoport. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cryoport's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cryoport Margin History

Cryoport Gross marginCryoport Profit marginCryoport EBIT marginCryoport Profit margin
2026e42.59 %-14.51 %-14 %
2025e42.59 %-19.5 %-19.71 %
2024e42.59 %-43.45 %-52.64 %
202342.59 %-28.12 %-46.12 %
202243.78 %-13.44 %-19.09 %
202143.4 %-8 %-127.45 %
202046.12 %-38.12 %-95.3 %
201951.33 %-52.21 %-53.98 %
201852.04 %-43.88 %-48.98 %
201750 %-65.83 %-65.83 %
201640.98 %-100 %-170.49 %
201532.2 %-147.46 %-255.93 %
201430.77 %-143.59 %-312.82 %
201314.81 %-188.89 %-725.93 %
2012-45.45 %-572.73 %-581.82 %
2011-133.33 %-1,233.33 %-1,300 %
2010-160 %-1,120 %-1,240 %
2009-600 %-4,200 %-5,700 %
200842.59 %0 %0 %
2007-300 %-3,000 %-4,600 %
2006-100 %-2,100 %-2,300 %

Cryoport Stock Sales Revenue, EBIT, Earnings per Share

The Cryoport earnings per share therefore indicates how much revenue Cryoport has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cryoport earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cryoport's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cryoport’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cryoport's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cryoport Revenue, EBIT and net profit per share

DateCryoport Sales per ShareCryoport EBIT per shareCryoport Earnings per Share
2026e5.69 undefined0 undefined-0.8 undefined
2025e5.2 undefined0 undefined-1.02 undefined
2024e4.77 undefined0 undefined-2.51 undefined
20234.79 undefined-1.35 undefined-2.21 undefined
20224.84 undefined-0.65 undefined-0.92 undefined
20214.85 undefined-0.39 undefined-6.18 undefined
20202.04 undefined-0.78 undefined-1.94 undefined
20191.01 undefined-0.53 undefined-0.55 undefined
20180.7 undefined-0.3 undefined-0.34 undefined
20170.52 undefined-0.34 undefined-0.34 undefined
20160.4 undefined-0.4 undefined-0.68 undefined
20150.81 undefined-1.19 undefined-2.07 undefined
20140.78 undefined-1.12 undefined-2.44 undefined
20130.66 undefined-1.24 undefined-4.78 undefined
20120.35 undefined-2.03 undefined-2.06 undefined
20110.25 undefined-3.08 undefined-3.25 undefined
20100.45 undefined-5.09 undefined-5.64 undefined
20090.25 undefined-10.5 undefined-14.25 undefined
20080 undefined-10.67 undefined-55.67 undefined
20070.33 undefined-10 undefined-15.33 undefined
20060.33 undefined-7 undefined-7.67 undefined

Cryoport business model

Cryoport, Inc. is a leading provider of temperature control and logistics solutions for the life science industry. The company was founded in 1999 and is headquartered in Irvine, California. Cryoport is listed on the NASDAQ stock exchange and offers a wide range of products and services to support temperature control requirements in the storage, transportation, and distribution of biological materials. Cryoport is one of the most popular companies on Eulerpool.com.

Cryoport SWOT Analysis

Strengths

Cryoport Inc boasts a strong and established reputation as a leading provider of temperature-controlled logistics solutions for the life sciences industry. With their specialized expertise in cryogenic shipping, Cryoport has developed a highly advanced and reliable technology platform to safeguard the transport of sensitive biologics, pharmaceuticals, and other life-saving materials. This technological prowess has allowed Cryoport to secure numerous high-profile partnerships with top companies in the healthcare and biotech sectors, solidifying their dominant position in the market.

Furthermore, Cryoport's extensive global network of over 650 locations, including strategic partnerships with major logistics providers, enables them to offer comprehensive end-to-end supply chain solutions, facilitating the efficient and safe delivery of temperature-sensitive products across borders.

Weaknesses

One notable weakness for Cryoport is the high dependency on the life sciences industry. Any significant downturn or disruption in the industry could have an adverse impact on Cryoport's financial performance. Diversification into other sectors or industries could mitigate this risk and provide a more stable revenue base.

Opportunities

The rapid growth of the biopharmaceutical industry presents significant opportunities for Cryoport. As the demand for personalized medicine and cell-based therapies continues to rise, the need for specialized cryogenic shipping solutions will increase accordingly. Cryoport can leverage its existing technology and expertise to capture a larger share of this expanding market and form new strategic alliances to further enhance their presence.

Additionally, Cryoport has the potential to expand its offerings beyond temperature-controlled logistics. They can explore partnerships or acquisitions in related fields such as cold chain packaging or supply chain analytics, further diversifying their revenue streams and strengthening their position as a comprehensive solution provider.

Threats

Increased competition in the temperature-controlled logistics space poses a threat to Cryoport. As the industry continues to grow, new players may enter the market, offering similar or improved services. Cryoport must proactively invest in research and development to stay at the forefront of technological advancements and maintain their competitive edge.

Additionally, regulatory changes or stricter compliance requirements in the transportation of temperature-sensitive materials may pose challenges. Cryoport must stay updated with evolving regulations and ensure their operations comply with quality standards and guidelines set by regulatory bodies, both domestically and internationally.

Cryoport Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Cryoport historical P/E ratio, EBIT multiple, and P/S ratio

Cryoport shares outstanding

The number of shares was Cryoport in 2023 — This indicates how many shares 48.737 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cryoport earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cryoport's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cryoport’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cryoport's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cryoport stock splits

In Cryoport's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Cryoport.

Cryoport latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.4 -0.29  (27.66 %)2024 Q2
3/31/2024-0.36 -0.43  (-21.13 %)2024 Q1
12/31/2023-0.3 -1.31  (-338.71 %)2023 Q4
9/30/2023-0.31 -0.31  (0.35 %)2023 Q3
6/30/2023-0.24 -0.42  (-74.13 %)2023 Q2
3/31/2023-0.19 -0.16  (16.45 %)2023 Q1
12/31/2022-0.2 -0.24  (-21.7 %)2022 Q4
9/30/2022-0.14 -0.15  (-3.73 %)2022 Q3
6/30/2022-0.15 -0.23  (-49.25 %)2022 Q2
3/31/2022-0.2 -0.31  (-53.69 %)2022 Q1
1
2
3

Eulerpool ESG Scorecard© for the Cryoport stock

Eulerpool World ESG Rating (EESG©)

43/ 100

🌱 Environment

32

👫 Social

50

🏛️ Governance

47

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
✅
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees31
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Cryoport shareholders

%
Name
Stocks
Change
Date
13.66994 % Brown Capital Management, LLC6,754,317-1,160,46012/31/2023
8.27178 % Morgan Stanley & Co. LLC4,087,0852,768,19812/31/2023
7.38349 % The Vanguard Group, Inc.3,648,18398,56912/31/2023
7.01089 % Cadian Capital Management LP3,464,079807,34012/31/2023
6.29649 % BlackRock Institutional Trust Company, N.A.3,111,096381,69112/31/2023
5.26037 % Impax Asset Management Ltd.2,599,149012/31/2023
4.03338 % MFS Investment Management1,992,895636,39512/31/2023
4.02630 % Fred Alger Management, LLC1,989,396-402,06212/31/2023
3.56650 % Invesco Advisers, Inc.1,762,207164,25412/31/2023
3.32474 % New York State Common Retirement Fund1,642,752378,34012/31/2023
1
2
3
4
5
...
10

Cryoport Executives and Management Board

Mr. Jerrell Shelton77
Cryoport Chairman of the Board, President, Chief Executive Officer (since 2012)
Compensation 2.49 M
Mr. Robert Stefanovich58
Cryoport Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Compensation 1.11 M
Mr. Mark Sawicki
Cryoport Senior Vice President, Chief Scientific Officer
Compensation 1.11 M
Mr. Richard Berman80
Cryoport Lead Independent Director
Compensation 439,994
Dr. Robert Hariri64
Cryoport Independent Director
Compensation 418,994
1
2
3

Most common questions regarding Cryoport

What values and corporate philosophy does Cryoport represent?

Cryoport Inc represents a strong commitment to ensuring the safe and efficient transportation of temperature-sensitive products, particularly in the life sciences and healthcare industries. With a focus on providing innovative logistics solutions, Cryoport leverages advanced packaging and monitoring technologies to maintain the integrity of biologic materials during transit. The company's corporate philosophy centers around reliability, quality, and customer satisfaction, aiming to meet the evolving needs of its clients while adhering to stringent regulatory requirements. By offering specialized cryogenic logistics services, Cryoport Inc enables companies to overcome the challenges of transporting vital, high-value biopharmaceuticals and other temperature-sensitive products worldwide.

In which countries and regions is Cryoport primarily present?

Cryoport Inc is primarily present in various countries and regions worldwide. This includes the United States, Europe, Asia, and other parts of the world.

What significant milestones has the company Cryoport achieved?

Cryoport Inc has achieved several significant milestones in its operations. One noteworthy milestone is the company's expansion of its global footprint, enabling it to provide its temperature-controlled logistics solutions to clients across the world. Additionally, Cryoport has established strategic partnerships with leading pharmaceutical and biotech companies, solidifying its position as a trusted provider in the life sciences industry. The company has also been recognized for its innovative technology and services, receiving multiple awards and accolades for its contributions to cold chain logistics. Overall, Cryoport Inc continues to demonstrate success and growth in its mission to ensure the safe transport of valuable biopharmaceuticals worldwide.

What is the history and background of the company Cryoport?

Cryoport Inc is a leading provider of temperature-controlled logistics solutions for the life sciences industry. Founded in 1999, the company has established itself as a trusted partner for the safe, secure, and reliable transportation of critical biological materials, including cell therapies, gene therapies, and reproductive tissues. Cryoport's advanced cryogenic shipping solutions and cloud-based logistics platform have revolutionized the way these sensitive materials are transported. With a strong focus on innovation and customer satisfaction, Cryoport has rapidly expanded its global footprint, serving biopharmaceutical companies, CROs, and academic institutions worldwide. As a trusted name in the industry, Cryoport continues to play a vital role in facilitating the advancement of life-saving therapies.

Who are the main competitors of Cryoport in the market?

The main competitors of Cryoport Inc in the market include World Courier, Marken, and DHL Life Sciences.

In which industries is Cryoport primarily active?

Cryoport Inc is primarily active in the healthcare and life sciences industries.

What is the business model of Cryoport?

The business model of Cryoport Inc revolves around providing temperature-controlled logistics solutions for the life sciences industry. Cryoport specializes in the transportation of highly valuable and sensitive biologic materials, including cell and gene therapies, reproductive cells, and vaccines. By leveraging their advanced cryogenic frozen shipping technology and digital monitoring systems, Cryoport ensures the safe and efficient transportation of these materials within a strict temperature range. With their global network of logistics partners and state-of-the-art facilities, Cryoport offers end-to-end cold chain solutions, allowing companies to ship their products across the world while maintaining their integrity and efficacy.

What is the P/E ratio of Cryoport 2024?

The Cryoport P/E ratio is -2.96.

What is the P/S ratio of Cryoport 2024?

The Cryoport P/S ratio is 1.56.

What is the Quality Investing of Cryoport?

The Quality Investing for Cryoport is 6/10.

What is the revenue of Cryoport 2024?

The expected Cryoport revenue is 235.82 M USD.

How high is the profit of Cryoport 2024?

The expected Cryoport profit is -124.15 M USD.

What is the business model of Cryoport

Cryoport Inc is a leading company in the field of biopharmaceutical cold chain logistics and offers innovative solutions for the transportation of sensitive and vital biological materials. The company was founded in 1999 and is headquartered in Irvine, California. Cryoport Inc serves over 500 pharmaceutical, biotechnology, and clinical trial customers worldwide. The business model of Cryoport Inc includes multiple divisions and products that are specifically designed to meet the requirements of sensitive experimental materials and clinical products. One of Cryoport Inc's most important products is CryoportalTM, a web-based customer portal that allows customers to manage shipments, place orders, and track shipments in real-time. Cryoport Inc also operates a 24/7 customer portal with real-time support from a dedicated customer service team. Additionally, they offer the Cryoport Express Shipping SystemTM, which utilizes the latest cold chain logistics technology to ensure a reliable, secure, and controlled temperature environment during transportation. Cryoport Inc also offers dry shippers and top-loading cryogenic containers that are specifically designed for the transportation of frozen biological materials. Another interesting offering from Cryoport Inc includes customs services. Alongside their own team of customs specialists, Cryoport Inc also handles import and export customs clearance. Cryoport Inc also provides a wide range of clinical and commercial biologics logistics solutions, applicable to the delivery of therapeutics and clinical products as well as clinical trial logistics. Overall, Cryoport Inc can provide its customers with a complete cold chain logistics infrastructure and professional support from experts in clinical trial logistics projects. Cryoport Inc's business model is based on avoiding material losses and successful clinical trials, as well as monitoring and managing all transportation processes of biological materials. Customers of Cryoport Inc can also rely on the latest advancements in temperature-controlled logistics, specifically the use of cryogenic containers and troczen loads, to improve the quality of their supply chains and logistics processes, as well as the delivery times of their products. In summary, Cryoport Inc possesses a strong business model due to its broad product offering, innovative technologies, and global presence, allowing the company to operate successfully in the cold chain logistics industry. Cryoport Inc is constantly striving to improve its offerings and services in order to best meet the needs of its customers in the sensitive and fast-paced pharmaceutical industry.

What is the Cryoport dividend?

Cryoport pays a dividend of 0 USD distributed over payouts per year.

How often does Cryoport pay dividends?

The dividend cannot currently be calculated for Cryoport or the company does not pay out a dividend.

What is the Cryoport ISIN?

The ISIN of Cryoport is US2290503075.

What is the Cryoport WKN?

The WKN of Cryoport is A14THD.

What is the Cryoport ticker?

The ticker of Cryoport is CYRX.

How much dividend does Cryoport pay?

Over the past 12 months, Cryoport paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cryoport is expected to pay a dividend of 0 USD.

What is the dividend yield of Cryoport?

The current dividend yield of Cryoport is .

When does Cryoport pay dividends?

Cryoport pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cryoport?

Cryoport paid dividends every year for the past 0 years.

What is the dividend of Cryoport?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cryoport located?

Cryoport is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cryoport kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cryoport from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did Cryoport pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of Cryoport in the year 2023?

In the year 2023, Cryoport distributed 0 USD as dividends.

In which currency does Cryoport pay out the dividend?

The dividends of Cryoport are distributed in USD.

All fundamentals about Cryoport

Our stock analysis for Cryoport Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cryoport Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.